These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32205046)
1. Small molecule inhibitors of IκB kinase β: A chip-based screening and molecular docking simulation. Cho YW; Lim HJ; Han MH; Kim BC; Han S Bioorg Med Chem; 2020 May; 28(9):115440. PubMed ID: 32205046 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel Xie X; Tu J; You H; Hu B Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074 [TBL] [Abstract][Full Text] [Related]
3. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway. Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663 [TBL] [Abstract][Full Text] [Related]
4. Computational design and discovery of nanomolar inhibitors of IκB kinase β. Park H; Shin Y; Choe H; Hong S J Am Chem Soc; 2015 Jan; 137(1):337-48. PubMed ID: 25513719 [TBL] [Abstract][Full Text] [Related]
5. Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner. Napoleon JV; Singh S; Rana S; Bendjennat M; Kumar V; Kizhake S; Palermo NY; Ouellette MM; Huxford T; Natarajan A Chem Commun (Camb); 2021 May; 57(38):4678-4681. PubMed ID: 33977973 [TBL] [Abstract][Full Text] [Related]
6. Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKβ inhibitors. Park CH; Lee C; Yang JS; Joe BY; Chun K; Kim H; Kim HY; Kang JS; Lee JI; Kim MH; Han G Bioorg Med Chem Lett; 2014 Jun; 24(12):2655-60. PubMed ID: 24813730 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of IKKβ by celastrol and its analogues - an in silico and in vitro approach. Veerappan K; Natarajan S; Ethiraj P; Vetrivel U; Samuel S Pharm Biol; 2017 Dec; 55(1):368-373. PubMed ID: 27931154 [TBL] [Abstract][Full Text] [Related]
8. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening. Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872 [TBL] [Abstract][Full Text] [Related]
10. Novel IKKβ inhibitors discovery based on the co-crystal structure by using binding-conformation-based and ligand-based method. Huang JJ; Wu XW; Jia JM; Guo XK; Xue X; Jiang ZY; Zhang SL; Zhang XJ; Sun HP; You QD Eur J Med Chem; 2013 May; 63():269-78. PubMed ID: 23501112 [TBL] [Abstract][Full Text] [Related]
11. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages. De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306 [TBL] [Abstract][Full Text] [Related]
12. Adamantyl arotinoids that inhibit IκB kinase α and IκB kinase β. Lorenzo P; Ortiz MA; Alvarez R; Piedrafita FJ; de Lera AR ChemMedChem; 2013 Jul; 8(7):1184-98. PubMed ID: 23653373 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics. Guo F; Zhao S; Li X Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491 [TBL] [Abstract][Full Text] [Related]
14. Combination of pharmacophore model development and binding mode analyses: identification of ligand features essential for IκB kinase-beta (IKKβ) inhibitors and virtual screening based on it. Sun HP; Zhu J; Chen FH; Zhang SL; Zhang Y; You QD Eur J Med Chem; 2011 Sep; 46(9):3942-52. PubMed ID: 21708416 [TBL] [Abstract][Full Text] [Related]
15. In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking. Wang JL; Li L; Hu MB; Wu B; Fan WX; Peng W; Wei DN; Wu CJ Comput Biol Chem; 2019 Feb; 78():297-305. PubMed ID: 30605855 [TBL] [Abstract][Full Text] [Related]
16. IKKbeta inhibitors identification part II: ligand and structure-based virtual screening. Nagarajan S; Choo H; Cho YS; Oh KS; Lee BH; Shin KJ; Pae AN Bioorg Med Chem; 2010 Jun; 18(11):3951-60. PubMed ID: 20488717 [TBL] [Abstract][Full Text] [Related]
17. IKKβ inhibitor identification: a multi-filter driven novel scaffold. Nagarajan S; Choo H; Cho YS; Shin KJ; Oh KS; Lee BH; Pae AN BMC Bioinformatics; 2010 Oct; 11 Suppl 7(Suppl 7):S15. PubMed ID: 21106122 [TBL] [Abstract][Full Text] [Related]
18. The discovery of a novel IκB kinase β inhibitor based on pharmacophore modeling, virtual screening and biological evaluation. Li L; Gong S Future Med Chem; 2024 Mar; 16(6):531-544. PubMed ID: 38385164 [TBL] [Abstract][Full Text] [Related]
19. Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation. Elkamhawy A; Youn Kim N; Hassan AHE; Park JE; Yang JE; Elsherbeny MH; Paik S; Oh KS; Lee BH; Lee MY; Shin KJ; Pae AN; Lee KT; Roh EJ Bioorg Chem; 2019 Nov; 92():103261. PubMed ID: 31542718 [TBL] [Abstract][Full Text] [Related]